Keywords: phase, iii, lodotra, study, data, positive, swiss

Phase III Lodotra study data positive

Article | 28 January 2008

Print This

Swiss specialty drug developer Nitec Pharma says that data from a Phase III study of its rheumatoid arthritis candidate Lodotra, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in